Insider · CIK 0001763945
Michael Nally
Files at PPG (PPG INDUSTRIES INC), GENB (Generate Biomedicines, Inc.). First filing Mar 6, 2026, latest Mar 6, 2026.
In brief
Michael Nally files SEC Form 4 as director and CEO at GENB (Generate Biomedicines, Inc.), and also at PPG (PPG INDUSTRIES INC). Since Mar 6, 2026, Michael Nally has reported 1 open-market buy worth $240k and 0 open-market sells worth $0, the latest filed on Mar 6, 2026.
A track record needs three past buys with six months of prices behind them; Michael Nally has 0, so none is measured yet.
The newest scored trade: bought $240k of GENB on Mar 4, 2026, filed Mar 6, 2026, scored 63 (notable). In the last 12 months: 1 buy worth $240k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
GENB: Generate Biomedicines, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 63Notable | Generate Biomedicines, Inc. | $240k 20,000 shares | +4% | 0% from low-8% from high |
Transactions
Every row this insider has filed, 18 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | PPG PPG INDUSTRIES INC | AGrant or award Phantom Stock Unitsderivative | +98 | $105.50 | $10k | 10,437 | 29 d ago |
| Jun 12, 2026 | PPG PPG INDUSTRIES INC | AGrant or award Phantom Stock Unitsderivative | +56 | $119.34 | $6,720 | 10,339 | Jun 15, 2026 |
| Apr 15, 2026 | PPG PPG INDUSTRIES INC | MOption exercise Restricted Stock Unitsderivative | -1,849 | $0.00 | $0 | 0 | Apr 17, 2026 |
| Apr 15, 2026 | PPG PPG INDUSTRIES INC | MOption exercise Phantom Stock Unitsderivative | +1,849 | $107.72 | $199k | 10,283 | Apr 17, 2026 |
| Apr 16, 2026 | PPG PPG INDUSTRIES INC | AGrant or award Restricted Stock Unitsderivative | +1,684 | $0.00 | $0 | 1,684 | Apr 17, 2026 |
| Mar 12, 2026 | PPG PPG INDUSTRIES INC | AGrant or award Phantom Stock Unitsderivative | +73 | $100.73 | $7,331 | 8,434 | Mar 13, 2026 |
| Mar 4, 2026 | GENB Generate Biomedicines, Inc. | POpen-market purchase Common Stock | +20,000 | $12.00 | $240k | 572,707 | Mar 6, 2026 |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc. | CConversion Common Stockindirect: By MTN 2024 GST Trust | +658,327 | - | - | 1,316,654 | Mar 2, 2026 |
| Feb 26, 2026 | GENB Generate Biomedicines, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +844,595 | $0.00 | $0 | 844,595 | Mar 2, 2026 |
| Feb 26, 2026 | GENB Generate Biomedicines, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +844,595 | $0.00 | $0 | 844,595 | Mar 2, 2026 |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc. | CConversion Series A Preferred Stockderivativeindirect: By MTN 2024 GST Trust | -1,000,000 | $0.00 | $0 | 0 | Mar 2, 2026 |
| Dec 12, 2025 | PPG PPG INDUSTRIES INC | AGrant or award Phantom Stock Unitsderivative | +75 | $103.54 | $7,807 | 8,361 | Dec 15, 2025 |
| Sep 12, 2025 | PPG PPG INDUSTRIES INC | AGrant or award Phantom Stock Unitsderivative | +63 | $110.72 | $6,963 | 8,285 | Sep 15, 2025 |
| Jun 12, 2025 | PPG PPG INDUSTRIES INC | AGrant or award Phantom Stock Unitsderivative | +40 | $112.03 | $4,532 | 8,222 | Jun 16, 2025 |
| Apr 16, 2025 | PPG PPG INDUSTRIES INC | MOption exercise Restricted Stock Unitsderivative | -1,368 | $0.00 | $0 | 0 | Apr 18, 2025 |
| Apr 16, 2025 | PPG PPG INDUSTRIES INC | MOption exercise Phantom Stock Unitsderivative | +1,368 | $98.42 | $135k | 8,182 | Apr 18, 2025 |
| Apr 17, 2025 | PPG PPG INDUSTRIES INC | AGrant or award Restricted Stock Unitsderivative | +1,849 | $0.00 | $0 | 1,849 | Apr 18, 2025 |
| Dec 12, 2024 | PPG PPG INDUSTRIES INC | AGrant or award Phantom Stock Unitsderivative | +47 | $124.02 | $5,787 | 6,462 | Dec 13, 2024 |
Questions about Michael Nally
Answered from the filings on this page, as of the latest one.
Is Michael Nally buying or selling?
In the last 12 months Michael Nally reported 1 open-market buy worth $240k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $240k of GENB on Mar 4, 2026. Grants, option exercises and tax withholding are not counted.
How did Michael Nally's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael Nally has 0.
Where does Michael Nally file Form 4?
Michael Nally has filed Form 4 at GENB (Generate Biomedicines, Inc.) as Chief Executive Officer; PPG (PPG INDUSTRIES INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.